These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35854693)

  • 1. The beneficial effects of exercise on glucose and lipid metabolism during statin therapy is partially mediated by changes of the intestinal flora.
    Wang L; Zhou B; Li X; Wang Y; Yang XM; Wang H; Yan J; Dong J
    Biosci Microbiota Food Health; 2022; 41(3):112-120. PubMed ID: 35854693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of changes in inflammatory factors, glucose and lipid metabolism indicators and adiponectin with alterations in intestinal flora in rats with coronary heart disease.
    Peng Y; Zhang N; Li WJ; Tan K; Zhou Y; She C; Chen HN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10118-10125. PubMed ID: 33090419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease.
    Wang L; Zhou W; Guo M; Hua Y; Zhou B; Li X; Zhang X; Dong J; Yang X; Wang Y; Wu Y; She J; Mu J
    Atherosclerosis; 2021 May; 325():16-23. PubMed ID: 33878520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate-Intensity Exercise Affects Gut Microbiome Composition and Influences Cardiac Function in Myocardial Infarction Mice.
    Liu Z; Liu HY; Zhou H; Zhan Q; Lai W; Zeng Q; Ren H; Xu D
    Front Microbiol; 2017; 8():1687. PubMed ID: 28919891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
    Rosenson RS; Kent ST; Brown TM; Farkouh ME; Levitan EB; Yun H; Sharma P; Safford MM; Kilgore M; Muntner P; Bittner V
    J Am Coll Cardiol; 2015 Jan; 65(3):270-7. PubMed ID: 25614424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Dai YY; Zhang HS; Zhang XG; Guan QG; Gao Y; Li YZ; Zhang YL; Jia DL; Sun YX; Qi GX; Tian W
    J Thorac Dis; 2017 May; 9(5):1345-1352. PubMed ID: 28616287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry.
    Gaisenok O; Martsevich S; Tripkosh S; Lukina Y
    Rev Port Cardiol; 2015 Feb; 34(2):111-6. PubMed ID: 25660463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.
    Caparrós-Martín JA; Lareu RR; Ramsay JP; Peplies J; Reen FJ; Headlam HA; Ward NC; Croft KD; Newsholme P; Hughes JD; O'Gara F
    Microbiome; 2017 Aug; 5(1):95. PubMed ID: 28793934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
    J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influencing factors of exercise tolerance in patients with myocardial infarction undergoing percutaneous coronary intervention revascularization in acute phase].
    Niu YQQ; Guo DJ; Jin ZX; Wang L; Ding RJ; Zhang TH; Han CY; Guo L
    Zhonghua Nei Ke Za Zhi; 2019 Oct; 58(10):763-769. PubMed ID: 31594175
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
    Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of maximal vs submaximal exertion on postprandial lipid levels in individuals with and without coronary heart disease.
    Aronov DM; Bubnova MG; Perova NV; Orekhov AN; Bobryshev YV
    J Clin Lipidol; 2017; 11(2):369-376. PubMed ID: 28502493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction.
    Celik T; Kursaklioglu H; Iyisoy A; Kose S; Kilic S; Amasyali B; Kardesoglu E; Isik E
    Coron Artery Dis; 2005 Aug; 16(5):321-6. PubMed ID: 16000891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective Effects of
    Deng SS; Chen J; Liu X; Dong XY; Zhang XL; Wang GQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):83-91. PubMed ID: 35048605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study.
    Jeong HY; Lee SY; Kim SH; Kim J
    Patient Prefer Adherence; 2020; 14():717-724. PubMed ID: 32308376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.